Sarver Vrooman Wealth Advisors’s Zimmer Biomet ZBH Stock Holding History

Sarver Vrooman Wealth Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$39.2K	Hold	441	–	–	0.02%	87
2026 Q2	$37.3K	Sell	441 -61	-12%	-$5.35K	0.02%	91
2026 Q1	$45.4K	Buy	502 +127	+34%	+$11.7K	0.03%	66
2025 Q4	$33.7K	Sell	375 -227	-38%	-$21.5K	0.02%	90
2025 Q3	$59.3K	Hold	602	–	–	0.04%	72
2025 Q2	$54.9K	Sell	602 -136	-18%	-$13.2K	0.04%	78
2025 Q1	$83.5K	Buy	+738	New	+$79K	0.06%	27

Other funds holding ZBH

DLA

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

MSV

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return

CPBTD

Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

MNBTD

Moody National Bank Trust Division Galveston, Texas $1.21B AUM 28.25% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Lawood & Co Williamsport, Pennsylvania $145M AUM 29.71% 1-Year Est. Return

CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return

Sarver Vrooman Wealth Advisors's ZBH Position: Q3 2026 in Review

Sarver Vrooman Wealth Advisors held its Zimmer Biomet (ZBH) position steady in Q3 2026 at 441 shares worth $39.2K. The position accounts for 0.02% of the portfolio, ranked #87.

Sarver Vrooman Wealth Advisors first reported a position in ZBH in Q1 2025 and has held it in 7 quarters since. The position peaked at $83.5K in Q1 2025. 28 funds tracked by Wall St. Rank hold ZBH as of Q3 2026.

Sarver Vrooman Wealth Advisors held 441 shares of Zimmer Biomet worth $39.2K as of Q3 2026.
Sarver Vrooman Wealth Advisors left its Zimmer Biomet share count unchanged in Q3 2026.
Zimmer Biomet made up 0.02% of Sarver Vrooman Wealth Advisors's portfolio in Q3 2026, its #87 holding.
Sarver Vrooman Wealth Advisors first reported a position in Zimmer Biomet in Q1 2025 and has held it in 7 quarters since.
Sarver Vrooman Wealth Advisors's Zimmer Biomet position peaked at $83.5K in Q1 2025.
28 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2026.

Based on Sarver Vrooman Wealth Advisors's 13F filing for Q3 2026, filed 1 Oct 2026.